Literature DB >> 26938045

Enantioselective Metabolism of Flufiprole in Rat and Human Liver Microsomes.

Chunmian Lin1, Yelong Miao1, Mingrong Qian2, Qiang Wang2, Hu Zhang2.   

Abstract

The enantioselective metabolism of flufiprole in rat and human liver microsomes in vitro was investigated in this study. The separation and determination were performed using a liquid chromatography system equipped with a triple-quadrupole mass spectrometer and a Lux Cellulose-2 chiral column. The enantioselective metabolism of rac-flufiprole was dramatically different in rat and human liver microsomes in the presence of the β-nicotinamide adenine dinucleotide phosphate regenerating system. The half-lives (t1/2) of flufiprole in rat and human liver microsomes were 7.22 and 21.00 min, respectively, for R-(+)-flufiprole, whereas the values were 11.75 and 17.75 min, respectively, for S-(-)-flufiprole. In addition, the Vmax of R-(+)-flufiprole was about 3-fold that of S-(-)-flufiprole in rat liver microsomes, whereas its value in the case of S-(-)-flufiprole was about 2-fold that of R-(+)-flufiprole in human liver microsomes. The CLint of rac-flufiprole also showed opposite enantioselectivy in rat and human liver microsomes. The different compositions and contents of metabolizing enzyme in the two liver microsomes might be the reasons for the difference in the metabolic behavior of the two enantiomers.

Entities:  

Keywords:  HPLC-MS/MS; enantioselective metabolism; flufiprole; liver microsomes

Mesh:

Substances:

Year:  2016        PMID: 26938045     DOI: 10.1021/acs.jafc.5b05853

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

1.  Design, synthesis, and insecticidal activity of a novel series of flupyrimin analogs bearing 1-aryl-1H-pyrazol-4-yl subunits.

Authors:  Fenghai Zhao; Xianjun Tang; Jiaxing Huang; Jiaqi Li; Yumei Xiao; Zhaohai Qin
Journal:  Front Chem       Date:  2022-10-03       Impact factor: 5.545

2.  Chiral 4-O-acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen.

Authors:  Tianzhe Chu; Chunyan Wang; Jing Wang; Heping Wang; Dandan Geng; Chensi Wu; Linlin Zhao; Ligang Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.